Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001792

CERILLIANT™ (+)-Norpropoxyphene maleate Solution, 1.0 mg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001792 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-792 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-792 Supplier MilliporeSigma Supelco Supplier No. N9131ML
 Restricted Item
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

Norpropoxyphene is a major urinary metabolite of the opioid analgesic drug propoxyphene. Norpropoxyphene's toxicity makes the parent drug more likely to cause death from overdose compared to similar mild opioid analgesics. This analytical reference standard is suitable for use as a starting material in the preparation of calibrators or controls for LC/MS or GC/MS testing methods in clinical toxicology, urine drug testing, forensic analysis or pain prescription monitoring.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 159208-83-0
Linear Formula C25H31NO6
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 1.0 mg/mL in methanol (as free base)
Formula Weight 441.52
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.